PLoS ONE (Jan 2022)

Increased risk of high-grade prostate cancer among testicular cancer survivors

  • Hong Zhang,
  • Hongmei Yang,
  • Sanjukta Bandyopadhyay,
  • Michael T. Milano,
  • Chunkit Fung,
  • Edward M. Messing,
  • Yuhchyau Chen

Journal volume & issue
Vol. 17, no. 2

Abstract

Read online

Introduction Testicular cancer survivors (TCS) have an increased risk of additional cancers, including prostate cancer. Our understanding of the natural history of prostate cancer in testicular cancer survivors is very limited due to its rare incidence. Methods Using the Surveillance, Epidemiology, and End Results (SEER) Registry from 1978 to 2011, we identified 282 TCS with subsequent prostate cancer and examined the tumor grade and clinical outcomes in contrast to men with primary prostate cancer in the general population. Results TCS with a subsequent prostate cancer diagnosis were more likely to be diagnosed at a younger age than men with primary prostate cancer (65.2% vs. 37.6% for age ≤65, 34.8% vs. 62.4% for age >65, pConclusions Prostate cancer in TCS was more likely to be diagnosed at a younger age and with higher grades. Risks of grade III/IV disease increased with longer latency between testicular and prostate cancer diagnoses. Radiotherapy for testicular cancer did not appear to have a significant impact on the outcome of subsequent prostate cancer.